Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT01047358
Brief Summary:
This non-interventional study is to monitor use in real practice in Korea including adverse events on Aromasin (Exemestane).
Detailed Description:
All cases at the participating institutions.
Study:
NCT01047358
Study Brief:
Protocol Section:
NCT01047358